Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
Guang Pu Xue Yu Guang Pu Fen Xi = Guang Pu
|
March 12, 2016
[Experimental Study of PMI Foam Composite Properties in Terahertz]
Li-yun Xing, Hong-liang Cui, Chang-cheng Shi, et al.
World Journal of Diabetes
|
February 1, 2021
Relationship between serum Dickkopf-1 and albuminuria in patients with type 2 diabetes
Ning-Ning Hou, Cheng-Xia Kan, Na Huang, et al.
Guang Pu Xue Yu Guang Pu Fen Xi = Guang Pu
|
July 24, 2018
[Current Status and Recent Advances in Research and Application of THz Technology in Articular Cartilage Detection]
Yu-ting Ma, Jin Zhang, Chang-cheng Shi, et al.
Immunology Letters
|
December 5, 2025
Lenvatinib-resistant liver cancer-derived HSP90α-containing extracellular vesicles enhance drug resistance via macrophage CXCL8 secretion
Xin-Wei Xu, Yue Zhang, Cheng-Wen Zhao, et al.
Cytokine
|
February 22, 2024
Interferon-α induces differentiation of cancer stem cells and immunosuppression in hepatocellular carcinoma by upregulating CXCL8 secretion
Yu-Ting Ma, Lu Zheng, Cheng-Wen Zhao, et al.
Clinical Immunology (Orlando, Fla.)
|
February 4, 2024
Tumor cell-derived LC3B<sup>+</sup>extracellular vesicles mediate the crosstalk between tumor microenvironment and immunotherapy efficacy in hepatocellular carcinoma via the HSP90α-IL-6/IL-8 signaling axis
Yong-Qiang Chen, Zhong-Song Man, Lu Zheng, et al.
Scientific Reports
|
January 19, 2017
Cullin 7 mediates proteasomal and lysosomal degradations of rat Eag1 potassium channels
Po-Hao Hsu, Yu-Ting Ma, Ya-Ching Fang, et al.
Pathology Oncology Research : POR
|
February 16, 2023
Corrigendum: Case report: Potential predictive value of MMR/MSI status and PD-1 expression in immunotherapy for urothelial carcinoma
Yu-Ting Ma, Yan Li, Li Yan, et al.
Pathology Oncology Research : POR
|
November 7, 2022
Case Report: Potential Predictive Value of MMR/MSI Status and PD-1 Expression in Immunotherapy for Urothelial Carcinoma
Yu-Ting Ma, Hong-Lan Yang, Li Yan, et al.
Frontiers in Immunology
|
November 29, 2023
Clinicopathological characteristics, molecular landscape, and biomarker landscape for predicting the efficacy of PD-1/PD-L1 inhibitors in Chinese population with mismatch repair deficient urothelial carcinoma: a real-world study
Yu-Ting Ma, Fang Hua, Xiu-Ming Zhong, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
Guang Pu Xue Yu Guang Pu Fen Xi = Guang Pu
|
March 12, 2016
[Experimental Study of PMI Foam Composite Properties in Terahertz]
Li-yun Xing, Hong-liang Cui, Chang-cheng Shi, et al.
World Journal of Diabetes
|
February 1, 2021
Relationship between serum Dickkopf-1 and albuminuria in patients with type 2 diabetes
Ning-Ning Hou, Cheng-Xia Kan, Na Huang, et al.
Guang Pu Xue Yu Guang Pu Fen Xi = Guang Pu
|
July 24, 2018
[Current Status and Recent Advances in Research and Application of THz Technology in Articular Cartilage Detection]
Yu-ting Ma, Jin Zhang, Chang-cheng Shi, et al.
Immunology Letters
|
December 5, 2025
Lenvatinib-resistant liver cancer-derived HSP90α-containing extracellular vesicles enhance drug resistance via macrophage CXCL8 secretion
Xin-Wei Xu, Yue Zhang, Cheng-Wen Zhao, et al.
Cytokine
|
February 22, 2024
Interferon-α induces differentiation of cancer stem cells and immunosuppression in hepatocellular carcinoma by upregulating CXCL8 secretion
Yu-Ting Ma, Lu Zheng, Cheng-Wen Zhao, et al.
Clinical Immunology (Orlando, Fla.)
|
February 4, 2024
Tumor cell-derived LC3B<sup>+</sup>extracellular vesicles mediate the crosstalk between tumor microenvironment and immunotherapy efficacy in hepatocellular carcinoma via the HSP90α-IL-6/IL-8 signaling axis
Yong-Qiang Chen, Zhong-Song Man, Lu Zheng, et al.
Scientific Reports
|
January 19, 2017
Cullin 7 mediates proteasomal and lysosomal degradations of rat Eag1 potassium channels
Po-Hao Hsu, Yu-Ting Ma, Ya-Ching Fang, et al.
Pathology Oncology Research : POR
|
February 16, 2023
Corrigendum: Case report: Potential predictive value of MMR/MSI status and PD-1 expression in immunotherapy for urothelial carcinoma
Yu-Ting Ma, Yan Li, Li Yan, et al.
Pathology Oncology Research : POR
|
November 7, 2022
Case Report: Potential Predictive Value of MMR/MSI Status and PD-1 Expression in Immunotherapy for Urothelial Carcinoma
Yu-Ting Ma, Hong-Lan Yang, Li Yan, et al.
Frontiers in Immunology
|
November 29, 2023
Clinicopathological characteristics, molecular landscape, and biomarker landscape for predicting the efficacy of PD-1/PD-L1 inhibitors in Chinese population with mismatch repair deficient urothelial carcinoma: a real-world study
Yu-Ting Ma, Fang Hua, Xiu-Ming Zhong, et al.
Page
of 4